<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8" />
<title>Opportunity Analysis Report</title>
<meta name="viewport" content="width=device-width,initial-scale=1" />
<style>
body{font-family:Arial,sans-serif;line-height:1.6;color:#333;max-width:1200px;margin:0 auto;padding:20px;background:#f5f5f5}
h1{color:#2c3e50;border-bottom:3px solid #2c3e50;padding-bottom:10px;margin-top:0}
h2{color:#34495e;margin-top:30px}
.summary,.metrics,.toc{background:#fff;padding:20px;border-radius:8px;margin-bottom:20px;box-shadow:0 2px 4px rgba(0,0,0,0.1)}
.metrics-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:20px;margin-top:15px}
.metric-box{background:#f8f9fa;padding:15px;border-radius:5px;border-left:4px solid #2c3e50}
.metric-label{font-size:.9em;color:#666;margin-bottom:5px}
.metric-value{font-size:1.5em;font-weight:bold;color:#2c3e50}
.toc ul{columns:2;column-gap:30px;margin:0;padding-left:20px}
.toc li{margin-bottom:8px;break-inside:avoid}
.toc a{color:#2c3e50;text-decoration:none}
.toc a:hover{text-decoration:underline}
table{background:#fff;box-shadow:0 2px 4px rgba(0,0,0,0.1);border-radius:8px;overflow:hidden;border-collapse:collapse;width:100%;margin-bottom:30px}
td{border:1px solid #ddd;padding:10px;vertical-align:top}
.th{background:#f0f0f0;font-weight:bold;width:25%}
.head{background:#2c3e50;color:#fff;font-weight:bold;padding:12px}
table.inner{width:100%;border-collapse:collapse;margin-top:8px}
table.inner td{border:1px solid #eee;padding:8px}
details > summary::-webkit-details-marker{display:none}
details[open] > summary{margin-bottom:8px}
@media print{.toc{page-break-after:always} body{background:#fff}}
</style>
</head>
<body>
<h1>Opportunity Analysis Report</h1>

<div class="summary">
<p><strong>Report Generated:</strong> 9/23/2025 at 5:01:26 PM</p>
<p><strong>Total Opportunities Analyzed:</strong> 10</p>
</div>

<div class="metrics">
<h2>Executive Summary</h2>
<div class="metrics-grid">
<div class="metric-box">
<div class="metric-label">Total Pipeline Value</div>
<div class="metric-value">$7,595,523</div>
</div>
<div class="metric-box">
<div class="metric-label">Average KF Score</div>
<div class="metric-value">66</div>
</div>
<div class="metric-box">
<div class="metric-label">Total Opportunities</div>
<div class="metric-value">10</div>
</div>
</div>
<div style="margin-top:20px;">
<p><strong>Stage Distribution:</strong> 5. Proposal/Price Quote: 3 | 4. Scoping: 2 | 6. Negotiate: 2 | 7. Final Contract Execution: 2 | Contract Red-line Received: 1</p>
<p><strong>Forecast Categories:</strong> Best Case: 7 | Commit: 2 | N/A: 1</p>
</div>
</div>

<div class="toc">
<h2>Table of Contents</h2>
<p style="color:#666;font-size:.9em;">Opportunities sorted by ACV (highest to lowest)</p>
<ul><li><a href="#opp-0">Compassus - Full Cycle RCM - $4,000,000</a></li><li><a href="#opp-1">Allegiance Healthcare - $2,000,000</a></li><li><a href="#opp-2">Baystate - PK Autonomous Coding co-dev - $1,000,000</a></li><li><a href="#opp-3">Chapters- Intake - $260,000</a></li><li><a href="#opp-4">Beebe Medical Center - Strongline - Duress - New Business - $135,000</a></li><li><a href="#opp-5">CA DSH - Athelas Home Hardware &amp; Service - New Business - $93,123</a></li><li><a href="#opp-6">Chesapeake Regional MC - Pilot conversion - $71,400</a></li><li><a href="#opp-7">Beth Israel Bayridge - Duress - Expansion - $20,000</a></li><li><a href="#opp-8">Beth Israel Anna Jaques - Strongline - Expansion - $16,000</a></li><li><a href="#opp-9">Boston Childrens - Strongline Asset Tracking - $0</a></li></ul>
</div>

<h2>Detailed Opportunity Analysis</h2>

<table id="opp-0">
<tr><td class="head" colspan="2">Opportunity #1</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Compassus - Full Cycle RCM</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Eric Valentin</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$4,000,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#28a745;">97</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Compassus is in Scoping for a high-value Full Cycle RCM program at $4,000,000 with a Best Case forecast. The engagement benefits from a strong KF score (97) and extensive Yes responses across the scorecard, including a long track record of stakeholder engagement and ROI-focused buy-in. Bluesheet data shows BS-00117, indicating formal WB alignment and planning. Next steps include onsite work and workflow discussions, signaling a green path to close if pricing and governance align. Top risk is model-inferred: scoping complexity and multi-stakeholder alignment; mitigation focuses on defining clear success criteria and governance with finance and IT.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Scoping complexity and cross-functional alignment.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Define clear success metrics and establish a governance cadence with CFO/IT stakeholders.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>8.12 - Onsite for RCM for workflows and FHA</li><li>(Proposed) Align on scope for the final proposal and governance plan</li><li>(Proposed) Secure executive sponsorship for sign-off</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Compassus - Full Cycle RCM</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Eric Valentin</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$4,000,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>97</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Compassus is in Scoping for a high-value Full Cycle RCM program at $4,000,000 with a Best Case forecast. The engagement benefits from a strong KF score (97) and extensive Yes responses across the scorecard, including a long track record of stakeholder engagement and ROI-focused buy-in. Bluesheet data shows BS-00117, indicating formal WB alignment and planning. Next steps include onsite work and workflow discussions, signaling a green path to close if pricing and governance align. Top risk is model-inferred: scoping complexity and multi-stakeholder alignment; mitigation focuses on defining clear success criteria and governance with finance and IT.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Scoping complexity and cross-functional alignment.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Define clear success metrics and establish a governance cadence with CFO/IT stakeholders.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>8.12 - Onsite for RCM for workflows and FHA</li><li>(Proposed) Align on scope for the final proposal and governance plan</li><li>(Proposed) Secure executive sponsorship for sign-off</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-1">
<tr><td class="head" colspan="2">Opportunity #2</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Allegiance Healthcare</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Mick Majewski</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$2,000,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">75</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Allegiance Healthcare is currently in the Scoping stage with a Best Case forecast and a sizable ACV of $2,000,000, indicating significant upside potential. The deal is supported by a Bluesheet (BS- 00160) and a KF score of 75, reflecting strong alignment on buying influences and ROI criteria. The onsite scheduling step in Buffalo is highlighted in Next Steps, signaling active engagement and field validation. The Win-Plan appears solid across multiple Yes responses in the scorecard, including investor influence and ROI criteria, though certain execution elements remain to be locked. Top risks are not driven by explicit red flags; rather, the model-inferred risk points to budget timing and decision readiness during Scoping, with mitigation focused on accelerating executive alignment and formalizing the procurement path.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Budget timing and decision readiness during Scoping.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Accelerate executive alignment; secure budget authority and define a concrete decision milestone with procurement.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.10 - scheduling onsite in buffalo</li><li>(Proposed) Confirm budget authority and schedule an executive briefing.</li><li>(Proposed) Align on contract path and ETA for LOA.</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Allegiance Healthcare</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Mick Majewski</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>4. Scoping</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$2,000,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>75</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Allegiance Healthcare is currently in the Scoping stage with a Best Case forecast and a sizable ACV of $2,000,000, indicating significant upside potential. The deal is supported by a Bluesheet (BS- 00160) and a KF score of 75, reflecting strong alignment on buying influences and ROI criteria. The onsite scheduling step in Buffalo is highlighted in Next Steps, signaling active engagement and field validation. The Win-Plan appears solid across multiple Yes responses in the scorecard, including investor influence and ROI criteria, though certain execution elements remain to be locked. Top risks are not driven by explicit red flags; rather, the model-inferred risk points to budget timing and decision readiness during Scoping, with mitigation focused on accelerating executive alignment and formalizing the procurement path.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Budget timing and decision readiness during Scoping.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Accelerate executive alignment; secure budget authority and define a concrete decision milestone with procurement.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.10 - scheduling onsite in buffalo</li><li>(Proposed) Confirm budget authority and schedule an executive briefing.</li><li>(Proposed) Align on contract path and ETA for LOA.</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-2">
<tr><td class="head" colspan="2">Opportunity #3</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Baystate - PK Autonomous Coding co-dev</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Amy Sullivan</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$1,000,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">70</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Baystate Medical Center is in Proposal/Price Quote with Best Case forecast and a $1M ACV, indicating strong momentum toward a contract. The deal is supported by a Bluesheet (BS- 00121) and a KF score of 70, reflecting robust influencer engagement and a well-developed business case. The Next Step notes upgrade workstreams and resource slots, suggesting that budget decisions are imminent pending approval to move to the amendment phase. The scorecard shows multiple Yes responses across the investor influence and ROI criteria, pointing to a compelling ROI narrative. Primary risk is model-inferred: budget timing and potential delays in amendment approval; mitigation includes locking budget authority and establishing a firm amendment timeline with the executive sponsor.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Budget timing and amendment approval risk.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Lock budget authority; set a firm amendment timeline and obtain sponsor sign-off.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.2 they have slotted in the upgrade and AC resources, assuming budget approval, moving to next phase which is amendment.</li><li>(Proposed) Prepare amendment scope and budget alignment.</li><li>(Proposed) Engage executive sponsor to drive closure.</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Baystate - PK Autonomous Coding co-dev</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Amy Sullivan</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$1,000,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>70</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Baystate Medical Center is in Proposal/Price Quote with Best Case forecast and a $1M ACV, indicating strong momentum toward a contract. The deal is supported by a Bluesheet (BS- 00121) and a KF score of 70, reflecting robust influencer engagement and a well-developed business case. The Next Step notes upgrade workstreams and resource slots, suggesting that budget decisions are imminent pending approval to move to the amendment phase. The scorecard shows multiple Yes responses across the investor influence and ROI criteria, pointing to a compelling ROI narrative. Primary risk is model-inferred: budget timing and potential delays in amendment approval; mitigation includes locking budget authority and establishing a firm amendment timeline with the executive sponsor.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Budget timing and amendment approval risk.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Lock budget authority; set a firm amendment timeline and obtain sponsor sign-off.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.2 they have slotted in the upgrade and AC resources, assuming budget approval, moving to next phase which is amendment.</li><li>(Proposed) Prepare amendment scope and budget alignment.</li><li>(Proposed) Engage executive sponsor to drive closure.</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-3">
<tr><td class="head" colspan="2">Opportunity #4</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Chapters- Intake</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Marc DeLaurentis</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>6. Negotiate</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$260,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">66</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Chapters Health System is negotiating in a Best Case scenario for an intake solution valued at $260,000. The record shows a comprehensive set of scorecard responses with multiple Yes points across the client’s buying influence and ROI expectations. The Next Step highlights CFO support and pricing for additional agent workflows, signaling cross-functional alignment and expansion potential. Bluesheet data is not present, but manager notes indicate ongoing engagement. Top risk is model-inferred: budget and CFO alignment; mitigation includes securing CFO buy-in and finalizing scope for add-on workflows.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: CFO alignment and budget constraints.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Secure CFO sign-off and finalize pricing for additional agent workflows.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/12 - Gustavo confirmed CFO supports. Provide pricing for add'l agent workflows. Wants intake live this year</li><li>(Proposed) Finalize scope for additional workflows and secure budget</li><li>(Proposed) Schedule CFO review and procurement approval</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Chapters- Intake</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Marc DeLaurentis</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>6. Negotiate</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$260,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>66</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Chapters Health System is negotiating in a Best Case scenario for an intake solution valued at $260,000. The record shows a comprehensive set of scorecard responses with multiple Yes points across the client’s buying influence and ROI expectations. The Next Step highlights CFO support and pricing for additional agent workflows, signaling cross-functional alignment and expansion potential. Bluesheet data is not present, but manager notes indicate ongoing engagement. Top risk is model-inferred: budget and CFO alignment; mitigation includes securing CFO buy-in and finalizing scope for add-on workflows.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: CFO alignment and budget constraints.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Secure CFO sign-off and finalize pricing for additional agent workflows.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/12 - Gustavo confirmed CFO supports. Provide pricing for add'l agent workflows. Wants intake live this year</li><li>(Proposed) Finalize scope for additional workflows and secure budget</li><li>(Proposed) Schedule CFO review and procurement approval</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-4">
<tr><td class="head" colspan="2">Opportunity #5</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Beebe Medical Center - Strongline - Duress - New Business</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$135,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#dc3545;">37</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Beebe Medical Center is in Proposal/Price Quote with a Best Case forecast and a modest ACV of $135,000. The engagement has a budget discussion noted (budget approval this week) and an anticipated go-live in January, with an EPIC project delay noted, and potential CEO funding if finance approval is not secured. The Bluesheet data is present, but there is limited explicit manager forecast content, suggesting a reliance on budget timing and Epic project sequencing. With a growing executive sponsorship, the opportunity shows potential for rapid advancement if the budget and Epic dependencies align. The primary risk is budget/timing and Epic integration delays; mitigation focuses on accelerating budget approval and coordinating with Epic timelines.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Budget timing and EPIC project delays.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Align budget approval with Epic project timeline and secure executive support to expedite contracting.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - budget update and alignment with finance</li><li>(Proposed) Confirm Epic integration milestones and sponsor sign-off</li><li>(Proposed) Prepare procurement package for 1/1 go-live</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Beebe Medical Center - Strongline - Duress - New Business</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$135,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/31/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>37</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Beebe Medical Center is in Proposal/Price Quote with a Best Case forecast and a modest ACV of $135,000. The engagement has a budget discussion noted (budget approval this week) and an anticipated go-live in January, with an EPIC project delay noted, and potential CEO funding if finance approval is not secured. The Bluesheet data is present, but there is limited explicit manager forecast content, suggesting a reliance on budget timing and Epic project sequencing. With a growing executive sponsorship, the opportunity shows potential for rapid advancement if the budget and Epic dependencies align. The primary risk is budget/timing and Epic integration delays; mitigation focuses on accelerating budget approval and coordinating with Epic timelines.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Budget timing and EPIC project delays.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Align budget approval with Epic project timeline and secure executive support to expedite contracting.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - budget update and alignment with finance</li><li>(Proposed) Confirm Epic integration milestones and sponsor sign-off</li><li>(Proposed) Prepare procurement package for 1/1 go-live</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-5">
<tr><td class="head" colspan="2">Opportunity #6</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>CA DSH - Athelas Home Hardware &amp; Service - New Business</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Eric Valentin</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>6. Negotiate</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Commit</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$93,123</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/25/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">69</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>CA Department of State Hospitals is in Negotiate with a committed forecast and ACV of $93,123. The engagement shows broad stakeholder involvement and a strong ROI narrative across the scorecard. There is no Bluesheet data or explicit manager notes, suggesting a standard procurement cycle with ongoing negotiation. The Next Step indicates awaiting signed contract and PO, signaling proximity to close contingent on procurement and legal alignment. Top risk is model-inferred: contracting timeline and procurement approvals; mitigation includes expediting PO routing and confirming funding source.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Contracting timeline and PO approvals.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Advance contracting steps and secure PO authorization; align with fiscal cycle.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.19 - Awaiting signed contract and PO</li><li>(Proposed) Confirm funding source and expedite procurement routing</li><li>(Proposed) Schedule final negotiation call with sponsor</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>CA DSH - Athelas Home Hardware &amp; Service - New Business</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Eric Valentin</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>6. Negotiate</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Commit</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$93,123</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/25/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>69</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>CA Department of State Hospitals is in Negotiate with a committed forecast and ACV of $93,123. The engagement shows broad stakeholder involvement and a strong ROI narrative across the scorecard. There is no Bluesheet data or explicit manager notes, suggesting a standard procurement cycle with ongoing negotiation. The Next Step indicates awaiting signed contract and PO, signaling proximity to close contingent on procurement and legal alignment. Top risk is model-inferred: contracting timeline and procurement approvals; mitigation includes expediting PO routing and confirming funding source.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Contracting timeline and PO approvals.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Advance contracting steps and secure PO authorization; align with fiscal cycle.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9.19 - Awaiting signed contract and PO</li><li>(Proposed) Confirm funding source and expedite procurement routing</li><li>(Proposed) Schedule final negotiation call with sponsor</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-6">
<tr><td class="head" colspan="2">Opportunity #7</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Chesapeake Regional MC - Pilot conversion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Marc DeLaurentis</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>Contract Red-line Received</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Commit</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$71,400</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/03/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#28a745;">82</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Chesapeake Regional Medical Group is in Contract Red-line Received with a committed forecast and a $71,400 ACV. The engagement features a robust scorecard with multiple indicators of executive influence and ROI sensitivity, and a live SOW is in review. The Next Step notes internal and external coordination to finalize the CORL and SOW. Bluesheet data is present (BS- 00013), suggesting a formal procurement track. Top risk is model-inferred: contract redlining and legal review pace; mitigation includes expedited redline review and prioritizing signature routing.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Contract redline and legal review pace.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Prioritize redline resolution and accelerate signature routing; designate a single point of contact for faster approvals.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>Virginia connecting internally and providing feedback on CORL. SOW sent for review. These should be last steps</li><li>(Proposed) Expedite SOW finalization and obtain signature</li><li>(Proposed) Align on post-signature onboarding plan</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Chesapeake Regional MC - Pilot conversion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Marc DeLaurentis</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>Contract Red-line Received</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Commit</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$71,400</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/03/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>82</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Chesapeake Regional Medical Group is in Contract Red-line Received with a committed forecast and a $71,400 ACV. The engagement features a robust scorecard with multiple indicators of executive influence and ROI sensitivity, and a live SOW is in review. The Next Step notes internal and external coordination to finalize the CORL and SOW. Bluesheet data is present (BS- 00013), suggesting a formal procurement track. Top risk is model-inferred: contract redlining and legal review pace; mitigation includes expedited redline review and prioritizing signature routing.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Contract redline and legal review pace.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Prioritize redline resolution and accelerate signature routing; designate a single point of contact for faster approvals.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>Virginia connecting internally and providing feedback on CORL. SOW sent for review. These should be last steps</li><li>(Proposed) Expedite SOW finalization and obtain signature</li><li>(Proposed) Align on post-signature onboarding plan</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>true</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-7">
<tr><td class="head" colspan="2">Opportunity #8</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Beth Israel Bayridge - Duress - Expansion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td></td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$20,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/30/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#dc3545;">40</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>BayRidge Hospital is earmarked for Final Contract Execution with a small ACV of $20,000 and an incomplete forecast status. The record shows limited Bluesheet data and no manager notes, suggesting the engagement is in a late-stage but low-visibility state. The scoring indicates limited ROI/buying-process data, but there is a clear pattern of interest and expansion potential if contract execution proceeds. The primary risk is limited forecast clarity and potential contracting delays; mitigation focuses on finalizing the signature and addressing any remaining vendor compliance steps.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Contracting/signature delays and limited forecast clarity.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Prioritize contract routing and secure a firm signature date; confirm all vendor/compliance requirements.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Confirm signature date and finalize contract language</li><li>(Proposed) Align with finance for PO issuance</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Beth Israel Bayridge - Duress - Expansion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td></td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$20,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/30/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>40</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>BayRidge Hospital is earmarked for Final Contract Execution with a small ACV of $20,000 and an incomplete forecast status. The record shows limited Bluesheet data and no manager notes, suggesting the engagement is in a late-stage but low-visibility state. The scoring indicates limited ROI/buying-process data, but there is a clear pattern of interest and expansion potential if contract execution proceeds. The primary risk is limited forecast clarity and potential contracting delays; mitigation focuses on finalizing the signature and addressing any remaining vendor compliance steps.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Contracting/signature delays and limited forecast clarity.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Prioritize contract routing and secure a firm signature date; confirm all vendor/compliance requirements.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Confirm signature date and finalize contract language</li><li>(Proposed) Align with finance for PO issuance</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-8">
<tr><td class="head" colspan="2">Opportunity #9</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Beth Israel Anna Jaques - Strongline - Expansion</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$16,000</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/19/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#ffc107;">66</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Anna Jaques Hospital is positioned for Final Contract Execution with a small ACV of $16,000 and Best Case forecast. The engagement shows investor influence and a broad set of ROI and buying-process criteria were acknowledged in the scorecard, indicating a strong business case and stakeholder alignment. The Next Step is waiting on signature, suggesting a tight path to close once legal and procurement complete. Bluesheet data is not present for this record, but the overall indicators suggest a favorable close pending signature. Top risk is model-inferred: potential legal/signature delays; mitigation focuses on expediting internal approvals and advancing contract routing.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Signature/contracting delays.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Streamline legal review and push for expedited signature routing; schedule a signature milestone with the sponsor.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Fast-track legal review and sign-off</li><li>(Proposed) Confirm signature target date with executive sponsor</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Beth Israel Anna Jaques - Strongline - Expansion</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>7. Final Contract Execution</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$16,000</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>9/19/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>66</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Anna Jaques Hospital is positioned for Final Contract Execution with a small ACV of $16,000 and Best Case forecast. The engagement shows investor influence and a broad set of ROI and buying-process criteria were acknowledged in the scorecard, indicating a strong business case and stakeholder alignment. The Next Step is waiting on signature, suggesting a tight path to close once legal and procurement complete. Bluesheet data is not present for this record, but the overall indicators suggest a favorable close pending signature. Top risk is model-inferred: potential legal/signature delays; mitigation focuses on expediting internal approvals and advancing contract routing.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Signature/contracting delays.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Streamline legal review and push for expedited signature routing; schedule a signature milestone with the sponsor.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li>9/7/25 - waiting on signature</li><li>(Proposed) Fast-track legal review and sign-off</li><li>(Proposed) Confirm signature target date with executive sponsor</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>

<table id="opp-9">
<tr><td class="head" colspan="2">Opportunity #10</td></tr>

<tr>
<td class="th">Opp Name</td>
<td>Boston Childrens - Strongline Asset Tracking</td>
</tr>
<tr>
<td class="th">Opp Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Account</td>
<td>—</td>
</tr>
<tr>
<td class="th">Product Line</td>
<td>—</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Cat</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">ACV</td>
<td><strong>$0</strong></td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/01/25</td>
</tr>
<tr>
<td class="th">KF Score</td>
<td><span style="font-weight:bold;color:#dc3545;">57</span></td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Boston Children’s Hospital is pursuing a Strongline asset-tracking initiative with an initial ACV of $0, indicating either a pilot or a very early-stage engagement. The forecast is Best Case, and the KF score is 57, reflecting mixed signals across the scorecard with some Yes responses and many Unknowns. A pilot is underway, as indicated by positive manager notes around the 2/13 pilot activity, and pricing has been provided for 5,000 tags. The Next Steps are limited, with no formal next-step details, suggesting the need for a defined pilot-to-contract plan. Primary risk is model-inferred: pilot-to-commercial transition risk; mitigation includes accelerating pilot live results and anchoring a definitive procurement plan.</td>
</tr>
<tr>
<td class="th">Risk</td>
<td><span style="color:#dc3545;">Model-inferred risk: Pilot-to-contract transition risk.</span></td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td><span style="color:#28a745;">Define a pilot success criteria and secure sponsor approval to convert to full contract.</span></td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li></li><li>(Proposed) Review pilot outcomes and establish contract milestones</li><li>(Proposed) Prepare a phased procurement plan and budget alignment</li></ul></td>
</tr>
<tr>
<td class="th" style="vertical-align:top;">All Fields</td>
<td>
<details open>
<summary style="cursor:pointer;color:#2c3e50;margin-bottom:8px;">Show everything returned by the AI</summary>
<table class="inner">

<tr>
<td class="th">Opportunity Name</td>
<td>Boston Childrens - Strongline Asset Tracking</td>
</tr>
<tr>
<td class="th">Owner</td>
<td>Joe Monaco</td>
</tr>
<tr>
<td class="th">Stage</td>
<td>5. Proposal/Price Quote</td>
</tr>
<tr>
<td class="th">Forecast Status</td>
<td>Best Case</td>
</tr>
<tr>
<td class="th">Actual A C V</td>
<td>$0</td>
</tr>
<tr>
<td class="th">Close Date</td>
<td>10/01/25</td>
</tr>
<tr>
<td class="th">Kf Score</td>
<td>57</td>
</tr>
<tr>
<td class="th">Summary</td>
<td>Boston Children’s Hospital is pursuing a Strongline asset-tracking initiative with an initial ACV of $0, indicating either a pilot or a very early-stage engagement. The forecast is Best Case, and the KF score is 57, reflecting mixed signals across the scorecard with some Yes responses and many Unknowns. A pilot is underway, as indicated by positive manager notes around the 2/13 pilot activity, and pricing has been provided for 5,000 tags. The Next Steps are limited, with no formal next-step details, suggesting the need for a defined pilot-to-contract plan. Primary risk is model-inferred: pilot-to-commercial transition risk; mitigation includes accelerating pilot live results and anchoring a definitive procurement plan.</td>
</tr>
<tr>
<td class="th">Top Risk</td>
<td>Model-inferred risk: Pilot-to-contract transition risk.</td>
</tr>
<tr>
<td class="th">Mitigation</td>
<td>Define a pilot success criteria and secure sponsor approval to convert to full contract.</td>
</tr>
<tr>
<td class="th">Next Steps</td>
<td><ul style="margin:0; padding-left:20px;"><li></li><li>(Proposed) Review pilot outcomes and establish contract milestones</li><li>(Proposed) Prepare a phased procurement plan and budget alignment</li></ul></td>
</tr>
<tr>
<td class="th">Has Bluesheet Data</td>
<td>false</td>
</tr>
</table>
</details>
</td>
</tr>
</table>
</body>
</html>
